INTENSIVE COURSE IN
Prescribing and Pharmacology of Controlled Drugs:
Critical Issues and Common Pitfalls
Presented by the Medical Association of the State of Alabama, the Alabama Board of Medical Examiners and the Alabama Board of Nursing
July 31-August 2 • Destin, Fla.
November 20-22 • Birmingham
Who Should Attend
The 12-hour Prescribing and Pharmacology course* is designed for physicians of all specialties, physician assistants and certified registered nurse practitioners and nurse midwives who need or wish to increase their knowledge and ability to effectively prescribe controlled medications that have the potential for misuse and abuse.*
* To obtain a QACSC, PAs, CRNPs and CNMs are required to take this entire 12-hour course. To renew a QACSC, PAs, CRNPs and CNMs must attend 4 hours of the 12-hour Prescribing of Controlled Drugs course, or any other Board-approved Prescribing of Controlled Substances course listed at www.albme.org/cscme.html
, every two years.
Prescribing of Controlled Drugs*
This intensive course will enhance the healthcare professional’s ability to effectively prescribe controlled medications while maintaining patient access to pain medications and minimizing misuse and abuse.
Pharmacology of Controlled Drugs*
This course will enhance the healthcare professionals’ ability to effectively prescribe controlled medications and manage ongoing therapy, evaluating risks and potential benefits of opioid drugs.
Medication Assisted Treatment (MAT) Waiver Training (July 31st Only)
Medication Assisted Treatment (MAT) of Substance Use Disorders involves a combination of medications that targets the brain, and psychosocial interventions (e.g., counseling, skills development) aimed at improving treatment outcomes. The Medical Association of the State of Alabama has partnered with Providers Clinical Support System (PCSS) to present this 8-hour course led by a PCSS clinical expert. PCSS is a program funded by the Substance Abuse and Mental Health Services Administration created in response to the opioid overdose epidemic to train primary care providers in the evidence-based prevention and treatment of opioid use disorders and treatment of chronic pain.
Funding for this initiative was made possible (in part) by grant no. 1H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Agenda, Brochure and Registration Information is coming soon